The most recent issue of the journal Pharmaceutical Statistics has published this article which re-analyses R&D productivity. It addresses the suggestions by people in the industry that “there are grounds for ‘cautious optimism’ that the industry ‘turned the corner’ in 2008 and is ‘on the comeback trail’.”
“We believe that this analysis is flawed and most probably wrong. We present an alternative analysis of these same data to suggest that the industry is not yet ‘out of the woods’ and suggest that many of the systemic issues affecting pharmaceutical R&D productivity are still being resolved.”
The full article can be accessed here.
by Dennis Lendrem, Stephen J. Senn, Clare Lendrem and John D. Isaacs.